Advertisement
Advertisement
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:02PM EST
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 128.38 |
| Open | 128.88 |
| Bid | 128.21 x 1800 |
| Ask | 130.68 x 1000 |
| Day's Range | 128.03 - 130.46 |
| 52 Week Range | 105.32 - 131.60 |
| Volume | |
| Avg. Volume | 5,159,185 |
| Market Cap | 231.466B |
| Beta (5Y Monthly) | 0.67 |
| PE Ratio (TTM) | 40.82 |
| EPS (TTM) | 3.19 |
| Earnings Date | Jan 25, 2022 - Jan 31, 2022 |
| Forward Dividend & Yield | 1.80 (1.39%) |
| Ex-Dividend Date | Oct 14, 2021 |
| 1y Target Est | 132.05 |
- News Direct
A Lasting Impact Through Better Medicine Adherence
1 in 2 people don't take their treatment. Abbott is taking action with a:care.
- Zacks
Abbott (ABT) Nutrition Sales Strong Amid Spike in COVID Cases
Abbott (ABT) is registering strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.
- Zacks
The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp
The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2021 Yahoo. All rights reserved.
